Latest filing published 21 Aug 2009 for NOVEN PHARMACEUTICALS INC, €543k.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
All filings by Phillip M. Satow on record concern Noven Pharmaceuticals Inc. Over a trading history stretching from 14 August 2007 to 27 August 2009, the count stands at 17 filings.
On the market, this insider has only ever bought: 12 purchases, €183k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.
The median purchase comes to €9,642.
The latest filing, published on 27 August 2009, reports a transaction of €105k in Noven Pharmaceuticals Inc. The last insider purchase was made public on 16 June 2008, 6,704 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations